← back to search

Aaron D. Gitler

Stanford University · US
Area of research
Neurology · Genetics
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Genetic Neurodegenerative Diseases, and RNA Research and Splicing.
h-index
76
citations
29,125
works
253
NIH funding
primary concept
Biology
email

Recent publications

A molecular atlas of adult C. elegans motor neurons reveals ancient diversity delineated by conserved transcription factor codes
Cell Reports 2024cited by 34position: middledoi
Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes
Brain 2024cited by 7position: middledoi
Challenges of profiling motor neuron transcriptomes from human spinal cord
Neuron 2023cited by 23position: lastdoi
FTLD targets brain regions expressing recently evolved genes
medRxiv 2023cited by 1position: middledoi
TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A
Nature 2022cited by 561position: lastdoi
The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems
Nature Communications 2022cited by 130position: middledoi
The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems. Source data
Zenodo (CERN European Organization for Nuclear Research) 2022cited by 1position: middledoi
The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems. Source data
Zenodo (CERN European Organization for Nuclear Research) 2022cited by 0position: middledoi
Neurotoxic reactive astrocytes induce cell death via saturated lipids
Nature 2021cited by 560position: middledoi
A prion-like protein regulator of seed germination undergoes hydration-dependent phase separation
Cell 2021cited by 227position: middledoi
p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)
Cell 2021cited by 168position: lastdoi
<i>C9orf72</i> -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility
Science Advances 2021cited by 90position: middledoi
Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
Nature Communications 2020cited by 280position: middledoi
BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain
Cell Systems 2020cited by 85position: middledoi
Evolution of a Human-Specific Tandem Repeat Associated with ALS
The American Journal of Human Genetics 2020cited by 60position: middledoi
Spontaneous driving forces give rise to protein−RNA condensates with coexisting phases and complex material properties
Proceedings of the National Academy of Sciences 2019cited by 550position: lastdoi
Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity
Acta Neuropathologica 2019cited by 41position: middledoi
Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains
Cell 2018cited by 476position: middledoi
Stress Granule Assembly Disrupts Nucleocytoplasmic Transport
Cell 2018cited by 425position: middledoi
CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity
Nature Genetics 2018cited by 237position: lastdoi
Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene
SSRN Electronic Journal 2018cited by 32position: middledoi
Neurodegenerative disease: models, mechanisms, and a new hope
Disease Models & Mechanisms 2017cited by 733position: firstdoi
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Nature 2017cited by 578position: lastdoi
Glycolytic Enzymes Coalesce in G Bodies under Hypoxic Stress
Cell Reports 2017cited by 205position: middledoi
Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD
Scientific Reports 2016cited by 280position: middledoi
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
Nature Communications 2016cited by 207position: middledoi
ATXN2 trinucleotide repeat length correlates with risk of ALS
Neurobiology of Aging 2016cited by 129position: middledoi
Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
Neuron 2016cited by 85position: middledoi
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Science 2015cited by 979position: middledoi
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
Nature Neuroscience 2015cited by 635position: lastdoi

Grants

Innovating next generation technologies to define mechanisms of neurodegenerative disease and devise therapeutic strategies
NIH1R35NS137159-01$1,136,4842024–2032Contact PIRePORTER
Innovating next generation technologies to define mechanisms of neurodegenerative disease and devise therapeutic strategies
NIH5R35NS137159-02$1,125,5302024–2032Contact PIRePORTER
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
NIH3U54NS123743-04S1$53,9002024–2026Contact PIRePORTER
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
NIH1U54NS123743-01$1,722,0032021–2026Contact PIRePORTER
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
NIH5U54NS123743-05$1,572,7822021–2026Contact PIRePORTER
Human Biomarkers Core
NIH5U54NS123743-02$355,1752021–2026Contact PIRePORTER
Human Biomarkers Core
NIH5U54NS123743-04$353,7862021–2026Contact PIRePORTER
Human Biomarkers Core
NIH5U54NS123743-03$352,1602021–2026Contact PIRePORTER
2020 Molecular & Cellular Neurobiology Gordon Research Conference and Gordon Research Seminar
NIH1R13NS116996-01$10,3372021–2022Contact PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreading of neurodegenerative disease
NIH1R01AG064051-01A1$607,6252020–2025PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease
NIH5R01AG064051-02$604,8132020–2025PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease
NIH5R01AG064051-03$601,9152020–2025PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease
NIH5R01AG064051-05$601,3472020–2026PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease
NIH5R01AG064051-04$601,3472020–2025PIRePORTER
Defining modifiers and mechanisms of RAN translation
NIH1RF1AG064690-01$2,824,7942019–2023PIRePORTER
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreading of neurodegenerative disease
NIH1R56AG064051-01$774,0922019–2020PIRePORTER
Defining modifiers and mechanisms of RAN translation
NIH2R01AG064690-02$771,8462019–2028PIRePORTER
Defining modifiers and mechanisms of RAN translation
NIH5R01AG064690-04$746,7662019–2028PIRePORTER
Defining modifiers and mechanisms of RAN translation
NIH5R01AG064690-03$744,3022019–2028PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH3R35NS097263-03S1$95,7762019–2020Contact PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH5R35NS097263-04$1,132,6102016–2024Contact PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH5R35NS097263-07$1,118,7732016–2024Contact PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH5R35NS097263-08$1,085,2102016–2024Contact PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH5R35NS097263-05$1,036,8342016–2024Contact PIRePORTER
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
NIH5R35NS097263-06$1,027,2732016–2024Contact PIRePORTER

Frequent collaborators

Steven Boeynaems · Children's Cancer Center8 papers (2015–2022)Ana Jovičić · Gene Therapy Laboratory5 papers (2013–2018)Alex S. Holehouse · Washington School of Psychiatry5 papers (2019–2022)James Shorter · University of Bonn5 papers (2012–2018) · 4 papers (2013–2020)J. Paul Taylor · University of Toronto4 papers (2015–2018)Oliver D. King · University of Massachusetts Chan Medical School4 papers (2012–2018)Lucy Shapiro · Palo Alto University3 papers (2022–2022)Jacob A. Blum · Stanford University3 papers (2021–2024)Vinson Lam · University of Michigan3 papers (2022–2022) · 3 papers (2014–2018)Gregor Bieri · Bayer (Switzerland)3 papers (2015–2018)Keren Lasker · Scripps Research Institute3 papers (2022–2022)Adam Briner · Weizmann Institute of Science3 papers (2022–2022)Ashok A. Deniz · Scripps Institution of Oceanography3 papers (2022–2022)Maarten Jacquemyn · KU Leuven3 papers (2022–2022) · 3 papers (2022–2022)Emma Stainton · Palo Alto University3 papers (2022–2022)Ludo Van Den Bosch · Allen Institute for Brain Science3 papers (2015–2019)William W. Seeley · Hammersmith Hospital3 papers (2016–2024)